1. Home
  2. NOAH vs CRMD Comparison

NOAH vs CRMD Comparison

Compare NOAH & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NOAH

Noah Holdings Limited

HOLD

Current Price

$11.51

Market Cap

754.2M

Sector

Finance

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$6.44

Market Cap

561.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOAH
CRMD
Founded
2005
2006
Country
China
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.2M
561.8M
IPO Year
2010
2009

Fundamental Metrics

Financial Performance
Metric
NOAH
CRMD
Price
$11.51
$6.44
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$10.75
$15.14
AVG Volume (30 Days)
127.8K
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.05%
N/A
EPS Growth
N/A
780.00
EPS
N/A
2.04
Revenue
N/A
$311,709,000.00
Revenue This Year
N/A
$1.10
Revenue Next Year
$3.79
N/A
P/E Ratio
$13.29
$3.09
Revenue Growth
N/A
617.03
52 Week Low
$7.67
$5.60
52 Week High
$12.84
$17.43

Technical Indicators

Market Signals
Indicator
NOAH
CRMD
Relative Strength Index (RSI) 44.51 34.53
Support Level $11.11 N/A
Resistance Level $12.41 $7.44
Average True Range (ATR) 0.38 0.27
MACD -0.11 -0.00
Stochastic Oscillator 22.49 23.40

Price Performance

Historical Comparison
NOAH
CRMD

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: